Apps Purchases: 10+ Million Software Purchases
Founded in 2010, APPS RUN THE WORLD is a leading technology intelligence and market-research company devoted to the application space. Leveraging a rigorous data-centric research methodology, we ask the simple B2B sales intelligence question: Who’s buying enterprise applications from whom and why?
Our global team of 50 researchers has been studying the digital transformation initiatives being undertaken by 2 million + companies including technographic segmentation of 10 million ERP, EPM, CRM, HCM, Procurement, SCM, Treasury software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Apps Run The World Buyer Insight and Technographics Customer Database has over 100 data fields that detail company usage of emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database, and different on-prem and cloud apps by function, customer size (employees, revenues), industry, country, implementation status, year deal won, partner involvement, Line of Business Key Stakeholders and key decision-makers contact details, including the systems being used by Fortune 1000 and Global 2000 companies.
Apply Filters For 10+ Million Software Purchases
- Analytics and BI
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | VAR/SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Alnylam Pharmaceuticals, Inc. | Life Sciences | 2002 | $1.0B | United States | Komodo Health | Komodo Healthcare Map | Analytics and BI | 2019 | n/a | In 2019, Alnylam Pharmaceuticals, Inc. implemented Komodo Healthcare Map to support commercial analytics and go to market prioritization. The deployment targeted the Global Commercial Excellence organization and adjacent commercial functions, aligning the Komodo Healthcare Map with account prioritization and field targeting workflows for sales and commercial operations. Komodo Healthcare Map was configured to deliver population level and patient level analytics, cohort identification, geospatial mapping, provider and specialty segmentation, and executive dashboards. The implementation emphasized interactive visualization and cohort discovery capabilities to support account-level engagement planning and commercial segmentation, with role specific dashboards provisioned for commercial leadership and field teams. Operational coverage focused on commercial excellence and GTM planning rather than clinical R&D workflows, with the Komodo Healthcare Map used to inform territory focus, target selection, and campaign prioritization. Implementation narrative centers on analytics-driven decision support, demand shaping, and evidence based targeting for sales and market access stakeholders. Governance changes included centralized access to Komodo Healthcare Map outputs and process adjustments for how targets are nominated and prioritized by the Global Commercial Excellence team. According to John Garcia, Global Commercial Excellence Lead, Komodo Health has really helped to focus people in the right area, and that’s been a huge boost for our organization, an explicit outcome cited by the customer. | |
 |
Astellas Pharma US | Life Sciences | 3000 | $700M | United States | Veeva Systems | Veeva Oncology Link | Analytics and BI | 2019 | n/a | In 2019, Astellas Pharma US implemented Veeva Oncology Link, a Veeva Systems application in the Analytics and BI category, to centralize identification and engagement of oncology scientific experts and support launch readiness. The deployment focused on using Veeva Oncology Link to strengthen relationships with oncology leaders while maintaining GDPR compliance for expert interactions. The implementation configured analytics-driven expert identification and engagement tracking capabilities, including expert profiling, segmentation, and engagement analytics to surface high-value scientific experts for launch planning. Veeva Oncology Link was used to instrument dashboards and workflows that align medical affairs and commercial engagement efforts, and to standardize outreach records and consent metadata required for compliant engagement. Governance centered on consent management and data privacy controls to ensure GDPR-compliant expert interactions, with process changes to capture and store consent status alongside engagement activities. Operational scope emphasized oncology medical and commercial functions responsible for launch strategy, and the configuration supported repeatable engagement workflows to enable coordinated scientific expert outreach and relationship strengthening. | |
 |
|
Life Sciences | 69310 | $42.2B | United Kingdom | Komodo Health | Komodo Health Aperture | Analytics and BI | 2019 | n/a |
|
|
|
|
|
Distribution | 45000 | $359.1B | United States | Komodo Health | Komodo Health iris | Analytics and BI | 2019 | n/a |
|
|
|
|
|
Media | 21273 | $7.2B | United Kingdom | SAP | SAP Analytics Cloud | Analytics and BI | 2019 | n/a |
|
|
|
|
|
Government | 3270 | $1.6B | United Kingdom | SAP | SAP BW (Business Warehouse) | Data Warehouse | 2019 | n/a |
|
|
|
|
|
Oil, Gas and Chemicals | 1183 | $551M | United Kingdom | SAP | SAP BW (Business Warehouse) | Data Warehouse | 2019 | n/a |
|
|
|
|
|
Consumer Packaged Goods | 7535 | $3.2B | United Kingdom | SAP | SAP BW (Business Warehouse) | Data Warehouse | 2019 | n/a |
|
|
|
|
|
Professional Services | 3000 | $2.3B | United Kingdom | SAP | SAP BW (Business Warehouse) | Data Warehouse | 2019 | n/a |
|
|
|
|
|
Professional Services | 3000 | $2.3B | United Kingdom | SAP | SAP BusinessObjects | Analytics and BI | 2019 | n/a |
|
|